BioVie(NASDAQ:BIVI): Advancing Transformative Therapies for Neurodegeneration and Liver Disease
9 months ago
1
BioVie is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease. The Company is developing NE3107 for Alzheimer’s (AD) and Parkinson’s (PD) and BIV201 for refractory ascites. BioVie is poised for significant catalysts in 2023, including data read out from its Alzheimer’s Phase 3 trial, expected in Q4 2023, as well as interim data read outs from the Company’s planned Phase 3 study in Parkinson’s. BioVie has multiple other efforts underway that may create additional catalysts and will be announced publicly when the Company deems appropriate. https://bit.ly/BioVie
Loading comments...
-
13:36
China Uncensored
1 hour agoPROOF China's Economy is in BIGGER Trouble Than We Thought!
1002 -
LIVE
LFA TV
5 hours agoDEPORT THEM ALL!! | LIVE FROM AMERICA 9.23.24 11am EST
4,086 watching -
2:07:39
Matt Kohrs
14 hours agoEverything You Need To Know About The Upcoming Trading Week || The MK Show
22.7K4 -
27:59
BonginoReport
4 hours agoP. Diddy: Trafficking, Blackmail, And The Fate Of The Republic (Ep.48) - 09/23/24
42.4K77 -
LIVE
Wendy Bell Radio
6 hours agoIt's A Democrat Dumpster Fire
11,876 watching -
2:14:17
AP4Liberty
3 hours agoTrump Leads Harris in Key Battleground States
16.3K1 -
2:23:24
Game On!
15 hours agoLet's be honest, the NFL misses Tom Brady
25.6K2 -
12:51
Adam Does Movies
19 hours agoAm I Racist? Movie Review - Is This Funny?
36.4K19 -
38:20
Degenerate Plays
19 hours agoDoctor, Doctor, Give Me The News - Assassin's Creed : Part 12
31.6K6 -
24:37
GameLeap RAID Shadow Legends
20 hours ago15 BEST EPICS You MUST MAX in 2024 (Every Faction) - Raid Shadow Legends Tier List
27.1K2